Spectrum Pharmaceuticals sales and marketing update

Spectrum launched Marqibo vincristine in the U.S. to treat Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) in patients with at least two relapses or in patients whose cancer has p...